Results 281 to 290 of about 213,470 (338)

Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus

Aging Cell, EarlyView.
In cohorts of lean controls, obese participants without Type 2 Diabetes Mellitus (T2DM) and obese T2DM participants, we find that T‐cell expression of senescence biomarkers is altered only in the T2DM participants and not with obesity alone. Moreover, high T‐cell p16 expression in the T2DM participants is associated with impaired bone cortical indices.
Caroline Hoong, Joshua N. Farr, David G. Monroe, Thomas A. White, Elizabeth J. Atkinson, Amanda Tweed, Allyson K. Palmer, Nathan K. LeBrasseur, Jad G. Sfeir, Sundeep Khosla   +9 more
wiley   +1 more source

Impact of Glucagon-Like Peptide-1 Receptor Agonist Exposure on Gastrointestinal Outcomes Among ICU Patients: A Multicenter Matched Cohort Study. [PDF]

Crit Care Explor
Gmehlin CG, Nemet M, Rizwan ZM, Ahmad S, Gajic O, Tekin A.   +5 more
europepmc   +1 more source

Assessing gout risk associated with GLP‐1 therapy in obese patients with type 2 diabetes: A retrospective cohort study

Rheumatology &Autoimmunity, EarlyView.
Justin Riley Lam, Emmanuel Otabor, Laith Alomari, Maxim Barnett, Bal Subedi, Het Hirpara, Freya Thummar   +6 more
wiley   +1 more source

Effect of the GLP‐1 receptor agonist exenatide on pro‐inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double‐blinded, placebo‐controlled clinical trial

Alcohol, Clinical and Experimental Research, EarlyView.
This study compared pro‐inflammatory and metabolic biomarker profiles between individuals with alcohol use disorder (AUD) and those without, and evaluated the impact of the GLP‐1 receptor agonist exenatide on these biomarkers in the AUD group. At baseline, individuals with AUD exhibited significantly elevated levels of IL‐6, hsCRP, and FGF‐21, and ...
Malthe E. B. Hviid, Lea A. N. Christoffersen, Mette K. Klausen, Thorsten Brodersen, Ole B. Pedersen, Sisse R. Ostrowski, Margit H. Larsen, Mette Kongstad, Mathias E. Jensen, Tina Vilsbøll, Anders Fink‐Jensen   +10 more
wiley   +1 more source

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies. [PDF]

Diabetes Metab J
Park JS, Kim KS, Choi HJ.
europepmc   +1 more source

Impact of Metabolic Surgery on Gestational Diabetes Mellitus: A Cohort Analysis

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background With the upsurge of obesity in Australia and worldwide, the incidence of metabolic surgery is increasing in women of reproductive age. Metabolic surgery reduces the rate of gestational diabetes mellitus, however, the risk remains about that for the general population.
Jasmine Wintour, Sarjana Afrin, Nicole Buxton, Mercy Madzivanyika, Katie Wynne   +4 more
wiley   +1 more source

Granuloma annulare after starting semaglutide. [PDF]

JAAD Case Rep
Jones T, Myers B, Konia T, Tartar DM, Rick J.   +4 more
europepmc   +1 more source

Semaglutide versus other GLP-1 receptor agonists in patients with MASLD. [PDF]

Hepatol Commun
Kuo CC, Li CH, Chuang MH, Huang PY, Kuo HT, Lai CC.   +5 more
europepmc   +1 more source

Patient Experiences and Treatment Satisfaction with Mini-Dose Glucagon as a Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan. [PDF]

J Clin Med
Algeffari M, Hussain S, Alsharidah M, Alkhalifah S, Almogbel T.   +4 more
europepmc   +1 more source